Biosimilar Antibodies
Biosimilar Antibodies
Functional-grade biosimilars for in vitro and in vivo experiments, validated to support innovation in drug discovery, molecular biology, and cell-based assays!
Why choose Biosimilar Antibodies?
- Cost-effective and reliable alternatives to reference biologics.
- Validated for diverse applications, including ELISAs, flow cytometry, and Western blotting.
- Suitable for biophysical characterization (SPR) and immunohistochemistry (IHC).
- Proven functionality in blocking, neutralization, co-stimulation, and depletion assays.
Our Biosimilar Range
Testimonials & Partners
"I ordered from AssayGenie for the first time and would like to share my satisfied impression. The article (Bevacizumab; IVMB0232) was used as a positive control and works excellently in Biacore SPR measurements and VEGF bioassay"
- G. Carsten, Fraunhofer (2024)
Delivery in 7-10 business days
24 hours on LiveChat & PhD level support
Cost-effective alternative to therapeutic mAbs
Ensuring reproducible results
cGMP & ISO Certification
Quality is at the core of everything we do.
Manufactured in state-of-the-art facilities, our products meet the highest standards, including current Good Manufacturing Practicies) cGMP, ISO 9001:2015, and ISO 13485:2016 certifications. These ensure consistent quality, customer-focused innovation, and reliable performance in every batch.
Biosimilar Production
Assay Genie's Biosimilar Development Pipeline creates research-grade biosimilars. We select and characterize reference biologics, then design and express them in host cells. Precise purification yields high-quality antibodies. Rigorous quality control validates structural integrity and functionality. This process ensures reliable biosimilar solutions for research.
Biosimilar Antibody Product Data
VivoGenie Biosimilars
Our VivoGenie Biosimilars are designed to meet the highest quality standards for research and preclinical applications. Featuring exceptional purity (≥95%) validated by SDS-PAGE, our biosimilars ensure reliable performance in WB, FC, and ELISA assays.
VivoGenie Biosimilars
With low endotoxin levels (≤1.0 EU/mg) and minimal aggregation (≥95% monomer verified by SEC), they are ideal for sensitive applications. Formulated in sterile PBS (pH 7.2) without preservatives, stabilizers, or carrier proteins.
Reference Biosimilars
Our Reference & Conjugated Biosimilars demonstrate exceptional performance in research assays. The ELISA assay on the left highlights a dose-dependent response using 0.2 µg of human TNF-α per well, confirming strong binding activity and neutralizing capabilities of the biosimilar.
Conjugated Biosimilars
The flow cytometry data on the right showcases precise binding to target cells, with clear separation between negative and positive populations, ensuring reliable results for functional studies.
Meet Some of the Genie Team!
At Assay Genie, we're here to help every step of the way. Whether you need guidance choosing the right product, updates on your order, or expert support after your purchase, we've got you covered.
Shane, Sales
Natalia, Tech Support
Chris, Sales
Beatriz, Logistics
Marina, Tech Support
Miren, Sales
José, Sales
David, Sales
FAQs & Citations
Research-grade biosimilars are laboratory-produced proteins that are designed to mimic the structure and function of approved biologic drugs. They are used in preclinical studies, assay development, and other non-clinical applications.
Research-grade biosimilars are intended for laboratory and research purposes only. They are not subject to the same regulatory scrutiny as therapeutic biosimilars, which must undergo clinical trials and approval processes for patient use.
No, research-grade biosimilars are designed to be similar in structure and function to reference biologics but are not identical. They are primarily used for assay development, drug screening, and in vitro/in vivo research.
They may be produced in similar systems (e.g., CHO cells, E. coli, yeast), but there can be differences in post-translational modifications, glycosylation patterns, or impurities.
Quality is assessed through purity analysis (SDS-PAGE, HPLC, Mass Spectrometry), bioactivity assays, and binding affinity tests (e.g., ELISA, SPR, BLI).
- Preclinical drug screening
- Assay development and validation (e.g., ELISA, Western Blot, Flow Cytometry)
- Mechanism of action studies
- Comparative studies against reference biologics
Yes, they can be used in in vivo models to study pharmacokinetics, pharmacodynamics, and efficacy before moving to clinical-grade biosimilars.
Product | Author | Citation |
|---|---|---|
Bikoriman et al. | ||
Leane et al. | ||
Rohani et al. | ||
Calvo et al. | ||
Turley et al. | ||
Wang et al. |
Biosimilar Resources - Blogs & Podcast Episodes
Quick Facts About EnavatuzumabWhat is Enavatuzumab?Enavatuzumab is a monoclonal antibody targeting the TWEAK receptor (Fn14), pivotal in tumor growth and immune regulation.What is the mechanism of action for Enavatuzumab?Enavatuzumab binds to Fn14, inhibiting signaling pathways that promote tumor cell proliferation and survival while [...]Quick Facts About EnavatuzumabWhat is Enavatuzumab?Enavatuzumab is a monoclonal antibody targeting the TWEAK receptor (Fn14), pivotal in tumor growth and immune regulation.What is the mechanism of action for Enavatuzumab?Enavatuzumab binds to Fn14, inhibiting signaling pathways that promote tumor cell proliferation and survival while [...]
Quick Facts About SiltuximabWhat is Siltuximab?Siltuximab is a monoclonal antibody targeting interleukin-6 (IL-6), a cytokine involved in inflammation and immune regulation.What is the mechanism of action for Siltuximab?Siltuximab binds to IL-6, preventing it from interacting with its receptor and mitigating downstream pro-inflammatory signaling.What [...]
Related Products
Additional Resources
